What Canntab Therapeutics does:
Canntab Therapeutics Ltd (CSE:PILL) (OTCMKTS:CTABF) is dedicated to the research and development of oral dosage formulations of cannabis.
The company’s delivery system treats a variety of ailments by delivering a uniform dosage of medicinal cannabis extract. This includes extended-release, immediate-release, and bi-layered tablets.
Canntab is the first to offer medical cannabis in pill form and its suite of products continues to grow. The company’s goal is to become a global leader in research in, production of, and education about hard pill oral dosage therapeutic cannabis.
The tablets are intended to treat disorders including post-traumatic stress disorder and arthritis, and they can also act as a pain management and appetite loss drug for patients undergoing cancer treatments.
You’re One Trade Away
Learn How To Trade Stocks & Options
Join our Trading Community 1-week student pass: linktr.ee/MarketRushTrading